The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …

Background To investigate the diagnostic performance of alpha-fetoprotein (AFP) and
neutrophil-to-lymphocyte ratio (NLR) as well as their combinations with other markers …

Background: The effectiveness of tumor markers in evaluating outcomes of patients with
hepatocellular carcinoma (HCC) remains to be clarified. Summary: The usefulness of the …

The prognostic impact of serum α-fetoprotein (AFP) level in patients with hepatocellular
carcinoma (HCC) is controversial. This study aimed to investigate the predictive ability of …

Background Serum α‐fetoprotein (AFP) is the most important tumor marker for
hepatocellular carcinoma (HCC). The reported predictive accuracy of AFP for HCC widely …

Background and aims The role of Alfa-fetoprotein (AFP) in the management of
hepatocellular carcinoma (HCC) is still debated, with differences in recommendations …

AIM: To explore the relationship between α-fetoprotein (AFP) and various clinicopathological
variables and different staging system of hepatocellular carcinoma (HCC) thoroughly …

Methods: Retrospective analysis of patients diagnosed with HCC between January 2011
and December 2018 was performed. Demographic, clinical and survival data were analyzed …

Background and Aims The prognostic ability of α-fetoprotein (AFP) for patients with
hepatocellular carcinoma (HCC) was examined by using different cutoff values. The optimal …

OBJECTIVES To assess, in a large multi-centric survey, diagnostic and prognostic reliability
of AFP, predictive factors, and any correlation with the tumor immunophenotype. METHODS …